catechin has been researched along with Amyloid Neuropathy Type 1 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelotti, P; Bartolini, S; Cappelli, F; Di Mario, C; Farsetti, S; Martone, R; Morini, S; Perfetto, F; Taborchi, G | 1 |
| Ando, Y; Masuda, T; Misumi, Y; Ogura, T; Toyoshima, R; Tsuda, Y; Ueda, M; Yamanaka, K | 1 |
| Altland, K; Aurich, M; aus dem Siepen, F; Bauer, R; Buss, SJ; Katus, HA; Kristen, AV; Steen, H | 1 |
| Arimori, T; Chirifu, M; Ikemizu, S; Kai, H; Koga, T; Kugimiya, M; Miyata, M; Mizuguchi, M; Momohara, M; Morino-Koga, S; Morioka, H; Nabeshima, Y; Nakamura, T; Sako, Y; Sato, T; Sho, M; Shuto, T; Suico, MA; Suwa, Y; Yamagata, Y | 1 |
| Almeida, MR; Ferreira, N; Saraiva, MJ | 2 |
| Altland, K; Buss, S; Dengler, TJ; Ehlermann, P; Giannitsis, E; Haberkorn, U; Hardt, S; Katus, HA; Kristen, AV; Lehrke, S; Linke, RP; Mereles, D; Röcken, C; Schnabel, PA; Schreiner, R; Steen, H; Wanker, EE | 1 |
1 trial(s) available for catechin and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.
Topics: Aged; Amyloid Neuropathies, Familial; Cardiomyopathies; Catechin; Cholesterol; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve; Plant Extracts; Tea | 2012 |
6 other study(ies) available for catechin and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study.
Topics: Amyloid Neuropathies, Familial; Case-Control Studies; Catechin; Cohort Studies; Female; Humans; Italy; Male; Neuroprotective Agents; Retrospective Studies; Treatment Outcome | 2018 |
Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.
Topics: Amyloid Neuropathies, Familial; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Catechin; Disease Models, Animal; Drug Evaluation, Preclinical; Green Fluorescent Proteins; Humans; Locomotion; Longevity; Neuroprotective Agents; Prealbumin; Recombinant Fusion Proteins; Staining and Labeling | 2018 |
Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amyloid; Amyloid Neuropathies, Familial; Catechin; Cohort Studies; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Plant Extracts; Tea | 2015 |
The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.
Topics: Amyloid Neuropathies, Familial; Binding Sites; Camellia sinensis; Catechin; Crystallography, X-Ray; Flavonoids; Humans; Phenols; Polyphenols; Prealbumin; Protein Conformation; Thyroxine | 2010 |
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Topics: Amyloid; Amyloid Neuropathies, Familial; Animals; Biomarkers; Catechin; Colon; Disease Models, Animal; Endoplasmic Reticulum Stress; Gastric Mucosa; Humans; Mice; Mice, Transgenic; Peripheral Nervous System; Prealbumin; Stomach | 2012 |
Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy.
Topics: Amyloid Neuropathies, Familial; Animals; Blotting, Western; Catechin; Curcumin; Gastrointestinal Tract; Immunohistochemistry; Masoprocol; Mice; Peripheral Nervous System; Polyphenols; Prealbumin | 2012 |